The novel treatment of this peptide represents a major development in the handling of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – providing enhanced glucose https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment